Compounds > clopidogrel

clopidogrel and Chronic Hepatitis B

clopidogrel has been researched along with Chronic Hepatitis B in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guidotti, LG; Iannacone, M; Sitia, G	1
Chao, Y; Chen, CC; Chen, TJ; Hu, YW; Huang, YH; Huo, TI; Lee, PC; Lin, HC; Liu, CJ; Su, CW; Wu, JC; Yeh, CM	1
Aiolfi, R; Chisari, FV; Di Lucia, P; Esposito, A; Fiocchi, A; Guidotti, LG; Iannacone, M; Mainetti, M; Mingozzi, F; Ruggeri, ZM; Sitia, G	1
Greenhill, C	1

Other Studies

4 other study(ies) available for clopidogrel and Chronic Hepatitis B

Article	Year
Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma. Journal of hepatology, 2013, Volume: 59, Issue:5 Topics: Animals; Aspirin; Blood Platelets; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Proliferation; Clopidogrel; Disease Models, Animal; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Mice; Platelet Aggregation Inhibitors; Ticlopidine	2013
Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection. Annals of surgical oncology, 2016, Volume: 23, Issue:Suppl 5 Topics: Adult; Aged; Aspirin; Carcinoma, Hepatocellular; Clopidogrel; Disease-Free Survival; Female; Gastrointestinal Hemorrhage; Hepatectomy; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Survival Rate; Taiwan; Ticlopidine	2016
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proceedings of the National Academy of Sciences of the United States of America, 2012, Aug-07, Volume: 109, Issue:32 Topics: Analysis of Variance; Animals; Aspirin; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase 2; Hepatitis B, Chronic; Liver; Liver Neoplasms; Membrane Proteins; Mice; Mice, Transgenic; Platelet Aggregation Inhibitors; Real-Time Polymerase Chain Reaction; Ticlopidine	2012
Hepatocellular carcinoma: could antiplatelet drugs be used to prevent HBV-associated hepatocellular carcinoma? Nature reviews. Gastroenterology & hepatology, 2012, Volume: 9, Issue:8 Topics: Animals; Carcinoma, Hepatocellular; Chemoprevention; Clopidogrel; Disease Models, Animal; Disease Progression; Hepatitis B, Chronic; Humans; Liver Neoplasms; Platelet Aggregation Inhibitors; Ticlopidine	2012